NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Joe Biden
    United States of America
    COVID-19
    Russia-Ukraine crisis
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / World News / Sputnik V: Russia's COVID-19 vaccine goes into production
    World

    Sputnik V: Russia's COVID-19 vaccine goes into production

    Sputnik V: Russia's COVID-19 vaccine goes into production
    Written by Shubham Sharma
    Aug 15, 2020, 04:54 pm 3 min read
    Sputnik V: Russia's COVID-19 vaccine goes into production

    Despite all the questions over safety and efficacy, Russia is moving ahead with what it claims is the first officially registered vaccine for COVID-19. The country, according to a report from Interfax news agency, has started the production of the shot, named Sputnik V, and will soon begin voluntary vaccinations. Here is all you need to know about it.

    First, a bit about the vaccine

    Developed by Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V is a vaccine that uses a weakened adenovirus, which causes the common cold, and the spike protein gene from the novel coronavirus to induce an antibody-based immune response. It is given in two doses at a gap of 21 days and was cleared for distribution by the Russian Health Ministry on August 11.

    Putin says vaccine is good, but concerns remain

    On August 11, when Russian President Vladimir Putin announced Sputnik V, he claimed that the vaccine "forms a stable immunity" and has passed necessary tests. However, medical experts, including AIIMS' Director, have expressed concerns over the safety and efficacy of the shot, as it has been cleared with less than 2 months of human trials and no data regarding its performance has been published.

    Phase-1/2 completed, Phase-3 in progress

    Notably, Sputnik V has completed only Phase-1/2 of human trials and is moving through Phase-3, which is slated to have 2,000 participants. Typically, vaccines are approved only after they clear all phases and are confirmed to be safe and effective. This is crucial to answer important questions like what the shot does (prevent infection or sickness) and how long the immunity lasts.

    Now, Russia is moving towards mass-producing the shot for public

    As Phase-3 continues, Russia is moving to mass-produce the shot to vaccinate the public simultaneously. Previously, it was reported that shot would be manufactured in September by Gamaleya and Sistema, a big Russian business house. But, if the latest report, which cites a Health Ministry official, is correct, the two organizations might already be manufacturing doses and ramping up their production.

    Roll-out by October, perhaps even sooner

    Once sufficient batches are manufactured, possibly by the end of August, the inoculation of high-risk groups such as medical professionals and senior citizens will be started. After that, the country will begin mass immunization drives to vaccinate the general public. This could possibly happen by late-October or perhaps sooner. Putin's daughter has already been inoculated and is said to be feeling well.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Russia News
    All India Institute Of Medical Sciences (AIIMS)
    Vaccine
    COVID-19

    Russia News

    Coronavirus: How soon could Russian vaccine be available in India? India
    Russian COVID-19 vaccine needs to be assessed, says AIIMS Director All India Institute Of Medical Sciences (AIIMS)
    Russia announces world's first COVID-19 vaccine; Putin's daughter gets vaccinated Vaccine
    Russia's COVID-19 vaccine candidate to be registered this week World Health Organization

    All India Institute Of Medical Sciences (AIIMS)

    COVAXIN: India's COVID-19 vaccine found safe in early trial COVID-19
    After dip, coronavirus cases rising again in Delhi Delhi High Court
    Sushant Rajput case: Family alleges murder, not abetment to suicide Central Bureau Of Investigation (CBI)
    Delhi man arrested for raping 12-year-old; victim in ICU Arvind Kejriwal

    Vaccine

    Pfizer's COVID-19 vaccine shows promise in human trials: Details here Pfizer
    Indians are searching ways to MAKE coronavirus vaccine at home India
    India likely to have COVID-19 vaccine by December: Adar Poonawalla Oxford
    Experts fear measles outbreak as coronavirus impacts immunization efforts West Bengal

    COVID-19

    Three indigenous coronavirus vaccines in trials, distribution plan ready: PM Narendra Modi
    COVID-19: Singer SP Balasubrahmanyam's health critical, on life support India
    Union Home Minister Amit Shah tests negative for coronavirus Independence Day
    Should you be wearing face masks while running or exercising? NewsBytes

    Love World News?

    Subscribe to stay updated.

    World Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023